A 35 year old female presents with a 2 week history of ...

There is a dose-response relationship between genotype 3 and the cure rate with IFN/R therapy. B. In genotype 3 infected patients there is no difference in efficacy between PEG/R and IFN/R. In genotype 1 infected patients, PEG/R is 10% more efficacious than standard IFN/R . The cure rate for Genotype 3 HCV with PEG/R approaches 80% ................
................

In order to avoid copyright disputes, this page is only a partial summary.